Category: Drug Discovery
Japan Drug Discovery
-
Japan Cancer Supportive Care Market, By Therapeutics Class (G-CSFs (Granulocyte-colony Stimulating Factors), ESAs (Erythropoiesis Stimulating Agents), Anti-emetics, Bisphosphonates, Opioids, NSAIDs, Others), By Region, Competition Forecast & Opportunities, 2020-2030F
... at USD 365.25 Million in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 2.25% through 2030. Vitamin supplements are designed to enhance the regular diet by providing ... Read More
-
Japan Mental Health Market Overview, 2029
... larger healthcare system in recent years. This dynamic terrain is an interesting and diverse subject of study since it is impacted by a multitude of elements, from cultural beliefs to economic realities. Japan, a country ... Read More
-
Japan Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Japan market. Also, factors that are driving and restraining the ankylosing spondylitis drugs market are highlighted ... Read More
-
Japan Eczema Therapeutics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Japan market. Also, factors that are driving and restraining the eczema therapeutics market are highlighted in the study. ... Read More
-
Japan Genetic Toxicology Testing Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Japan market. Also, factors that are driving and restraining the genetic toxicology testing market are highlighted ... Read More
-
Japan Cancer Therapeutics Market Assessment, By Applications [Lung Cancer, Blood Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Glioblastoma, Head & Neck Cancer, Malignant Meningioma, Mesothelioma, Melanoma, Others], By Therapeutics [Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Other], By Top Selling Drugs [Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, Temodar, Others], By End-user [Hospitals, Specialty Clinics, Cancer & Radiation Therapy Centers], By Region, By Opportunities and Forecast, FY2017-FY2031F
... Hormonal Therapy, Other], By Top Selling Drugs [Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, Temodar, Others], By End-user [Hospitals, Specialty Clinics, Cancer & Radiation Therapy Centers], By Region, ... Read More
-
Japan Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 4.00 billion by 2028, growing at a CAGR of 3.60% during the forecast period (2023-2028). The COVID-19 pandemic has had a substantial impact on the diabetes drugs market. The prevalence of diabetes in people ... Read More
-
Japan Migraine Therapeutics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Japan market. Also, factors that are driving and restraining the migraine therapeutics market are highlighted in the study. ... Read More
-
Japanese Encephalitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... clinical stage pipeline candidates under development as of H1- 2023. For each of the Japanese Encephalitis pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule type, and other ... Read More
-
Global Hepatitis B Virus (HBV) Vaccine Market: Analysis By End User (Adult & Pediatric), By Composition (Mono & Combination), By Region (The US, China, EU+UK, Japan & ROW), Size and Trends with Impact of COVID-19 and Forecast up to 2027
... and Forecast up to 2027 The global hepatitis B virus (HBV) vaccine market was valued at US$2.23 billion in 2021, and is predicted to grow to US$3.04 billion in 2027. The hepatitis B virus (HBV) ... Read More
Research Assistance
